Journal of Equine Veterinary Science
Volume 28, Issue 10 , Pages 603-607 , October 2008

The Role of Insulin in Endocrinopathic Laminitis

  • Catherine McGowan, BVSc, PhD, DipECEIM

      Affiliations

    • Corresponding Author InformationReprint requests: Catherine McGowan BVSc, PhD, DipECEIM, Equine Division, Faculty of Veterinary Science, University of Liverpool, Leahurst, Wirral. CH64 7TE. UK.

References 

  1. Johnson PJ, Messer NT, Slight SH, Wiedmeyer C, Buff P, Ganjam VK. Endocrinopathic laminitis in the horse. Clin Tech Equine Pract. 2004;3:45–56
  2. Schott HC. Pituitary pars intermedia dysfunction: equine Cushing's disease. Vet Clin North Am: Equine Pract. 2002;18:237–270
  3. Wilson MG, Nicholson WE, Holscher MA, Sherrell BJ, Mount CD, Orth DN. Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing's horses. Endocrinology. 1982;110:941–954
  4. McGowan CM, Neiger R. Efficacy of trilostane for the treatment of equine Cushing's syndrome. Equine Vet J. 2003;35:414–418
  5. McCluskey MJ, Kavenagh PB. Clinical use of triamcinolone acetonide in the horse (205 cases) and the incidence of glucocorticoid-induced laminitis associated with its use. Equine Vet Educ. 2004;16:86–89
  6. Bathe AP. The corticosteroid laminitis story: 3. The clinician's viewpoint. Equine Vet J. 2007;39:12–13
  7. Bailey SR, Elliott J. The corticosteroid laminitis story: 2. Science of if, when and how. Equine Vet J. 2007;39:7–11
  8. French KR, Pollitt CC. Equine laminitis: glucose deprivation and MMP activation induce dermo-epidermal searation in vitro. Equine Vet J. 2004;36:261–266
  9. Tiley HA, Geor RJ, McCutcheon LJ. Effects of dexamethasone administration on insulin resistance and components of insulin signaling and glucose metabolism in equine skeletal muscle. Am J Vet Res. 2008;69:51–58
  10. McGowan CM, Frost R, Pfeiffer DU, Neiger R. Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitor and prognostic value. Equine Vet J. 2004;36:295–298
  11. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem. 2005;51:931–938
  12. Reaven GM. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin North Am. 2004;33:283–303
  13. Johnson PJ, Ganjam VK. Laminitis, “hypothyroidism,” and obesity: a peripheral cushingoid syndrome in horses? Proceedings 17th Annual Forum of the American College of Veterinary Internal Medicine; 1999:192–194 (abstr).
  14. Johnson PJ. The equine metabolic syndrome peripheral Cushing's syndrome. Vet Clin North Am: Equine Pract. 2002;18:271–293
  15. Johnson PJ. Metabolic syndrome in horses. Proceedings 21st Annual Forum of the American College of Veterinary Internal Medicine. 2003;
  16. McGowan CM, Riley G. Long-term trilostane treatment for metabolic syndrome. Proceedings 43rd British Equine Veterinary Association Congress. 2004;103:(abstr)
  17. Treiber KH, Kronfeld DS, Hess TM, Byrd BM, Splan RK. Pre-laminitic metabolic syndrome in genetically predisposed ponies involves compensated insulin resistance. J Anim Physiol Anim Nutr. 2005;89:430–431
  18. Treiber KH, Kronfeld DS, Hess TM, Byrd BM, Splan RK, Staniar WB. Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies. J Am Vet Med Assoc. 2006;228:1538–1545
  19. Geor RJ, Thatcher CD, Pleasant RS, Elvinger F, Gay L, Werre SR. Prevalence of hyperinsulinemia in mature horses: relationship to adiposity. J Vet Intern Med. 2007;21:601;(abstr)
  20. McGowan CM, Geor RJ, McGowan TW. Prevalence and risk factors for hyperinsulinemia in ponies. J Vet Intern Med. 2008;22:734;(abstr)
  21. Pass MA, Pollitt S, Pollitt CC. Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis?. Equine Vet J. 1998;26:133–138
  22. Wattle O, Pollitt CC. Lamellar metabolism. Clin Tech Equine Pract. 2004;13:22–33
  23. Hunt DG, Ivy JL. Epinephrine inhibits insulin-stimulated muscle glucose transport. J Appl Physiol. 2002;93:1638–1643
  24. Huang H, Gazzola C, Pegg GG, Sillence MN. Effect of corticosterone on beta-adrenoceptor density in rat skeletal muscle. J Anim Sci. 1998;76:999–1003
  25. Asplin KE, McGowan CM, Pollitt CC, Curlewis J, Sillence MN. Role of insulin in glucose uptake in the equine hoof. J Vet Intern Med. 2007;21:668;(abstr)
  26. Hartge MM, Unger T, Kintscher U. The endothelium and vascular inflammation in diabetes. Diab Vasc Dis Res. 2007;4:84–88
  27. Singer G, Granger DN. Inflammatory responses underlying the microvascular dysfunction associated with obesity and insulin resistance. Microcirculation. 2007;14:375–387
  28. Rattigan S, Bussey CT, Ross RM, Richards SM. Obesity, insulin resistance, and capillary recruitment. Microcirculation. 2007;14:299–309
  29. Garner HE, Coffman JR, Hahn JW, Hutcheson DP, Tumbleson ME. Equine laminitis of alimentary origin: an experimental model. Am J Vet Res. 1975;36:441–444
  30. Galey FD, Whiteley HE, Goetz TE, Kuenstler AR, Davis CA, Beasley VR. Black walnut (Juglans nigra) toxicosis: a model for equine laminitis. J Comp Pathol. 1991;104:313–326
  31. Parsons CS, Orsini JA, Krafty R, Capewell L, Boston R. Risk factors for development of acute laminitis in horses during hospitalization: 73 cases (1997–2004). J Am Vet Med Assoc. 2007;230:885–889
  32. van Eps AW, Pollitt CC. Equine laminitis induced with oligofructose. Equine Vet J. 2006;38:203–208
  33. Asplin KE, Sillence MN, Pollitt CC, McGowan CM. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies. Vet J. 2007;174:530–535
  34. Field JR, Jeffcott LB. Equine laminitis: another hypothesis for pathogenesis. Med Hypotheses. 1989;30:203–210

 Refereed

PII: S0737-0806(08)00277-3

doi: 10.1016/j.jevs.2008.08.004

Journal of Equine Veterinary Science
Volume 28, Issue 10 , Pages 603-607 , October 2008

Article Tools